Solveig J. Pettersen

Oslo, 0379, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Combinatorial Effects of Free and Nanoencapsulated Forms of Cabazitaxel and RAS-Selective Lethal 3 in Breast Cancer Cells.

Combinatorial Effects of Free and Nanoencapsulated Forms of Cabazitaxel and RAS-Selective Lethal 3 in Breast Cancer Cells.

Journal: Pharmaceutics
Published: April 10, 2025

Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.

Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.

Journal: Breast cancer research : BCR
Published: March 03, 2025

Evaluation of HER2 Targeted Poly(Ethylene Glycol)-Poly(L-histidine) Copolymer Micelles in Breast Cancer Models.

Evaluation of HER2 Targeted Poly(Ethylene Glycol)-Poly(L-histidine) Copolymer Micelles in Breast Cancer Models.

Journal: Macromolecular bioscience
Published: January 20, 2025

The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy.

The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy.

Journal: British journal of cancer
Published: May 10, 2024

Breast cancer patient-derived explant cultures recapitulate in vivo drug responses.

Breast cancer patient-derived explant cultures recapitulate in vivo drug responses.

Journal: Frontiers in oncology
Published: September 09, 2022

2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)-Inducible Poly-ADP-Ribose Polymerase (TIPARP/PARP7) Catalytic Mutant Mice (TiparpH532A) Exhibit Increased Sensitivity to TCDD-Induced Hepatotoxicity and Lethality.

2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)-Inducible Poly-ADP-Ribose Polymerase (TIPARP/PARP7) Catalytic Mutant Mice (TiparpH532A) Exhibit Increased Sensitivity to TCDD-Induced Hepatotoxicity and Lethality.

Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: June 15, 2021

Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen.

Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen.

Journal: Molecular oncology
Published: August 16, 2020

Correction: Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation.

Correction: Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation.

Journal: RSC advances
Published: January 09, 2020

Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation.

Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation.

Journal: RSC advances
Published: September 12, 2019

Targeted Killing of Monocytes/Macrophages and Myeloid Leukemia Cells with Pro-Apoptotic Peptides.

Targeted Killing of Monocytes/Macrophages and Myeloid Leukemia Cells with Pro-Apoptotic Peptides.

Journal: Cancers
Published: April 18, 2019

Design, synthesis and biological evaluation of 6-substituted quinolines derived from cabozantinib as c-Met inhibitors.

Design, synthesis and biological evaluation of 6-substituted quinolines derived from cabozantinib as c-Met inhibitors.

Journal: Archiv der Pharmazie
Published: March 30, 2019

Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4.

Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4.

Journal: Molecular oncology
Published: December 22, 2017
Showing 1-12 of 21

Last Updated: 09/26/2026